Inactivation of Smad4 in gastric carcinomas

Steven M. Powell, Jeffrey C. Harper, Stanley R. Hamilton, C. Rahj Robinson, Oscar W. Cummings

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Allelic loss of chromosome 18q has been noted in intestinal type gastric adenocarcinomas. Smad4 is a gene located at 18q that was recently cloned in humans and found to be significantly altered in pancreatic cancers. We sought to determine whether Smad4 genetic alterations played a significant role in gastric tumorigenesis by studying 35 gastric adenocarcinomas of all histopathological types and pathological stages. Microdissected specimens were used for mutational analysis of Smad4 at the nucleotide level, including the entire coding region and intron/exon boundaries. Allelic imbalance was also analyzed at the Smad4 locus using two nearby micro-satellite markers. One case of apparent biallelic inactivation of Smad4 was found in our study of 35 gastric carcinomas. A nonsense point mutation at codon 334 was demonstrated, which, similar to other Smad4 mutations, is predicted to truncate the conserved COOH-terminal domain of this protein. This Smad4 C to T transition mutation was proven to be somatically acquired. Allelic loss was also noted on chromosome 18q at a marker near Smad4 in this mutated gastric cancer, apparently producing complete inactivation of Smad4 in this tumor. Significant 18q allelic loss (56% of 34 informative cases) was noted in our gastric carcinomas using microsatellite markers near the Smad4 locus, regardless of histological subtype or pathological stage. Additionally, three cases of microsatellite instability were observed. Thus, Smad4 inactivation was noted in our gastric carcinomas; however, this event was rare. The frequent loss of chromosomal arm 18q observed in gastric cancers suggests the presence of other tumor suppressor genes in this region that are involved in gastric tumorigenesis. Further studies are needed to identify these other targets of inactivation during gastric cancer development.

Original languageEnglish (US)
Pages (from-to)4221-4224
Number of pages4
JournalCancer Research
Volume57
Issue number19
StatePublished - Oct 1 1997

Fingerprint

Stomach
Carcinoma
Loss of Heterozygosity
Stomach Neoplasms
Carcinogenesis
Adenocarcinoma
Chromosomes
Allelic Imbalance
Microsatellite Instability
Mutation
Nonsense Codon
Tumor Suppressor Genes
Pancreatic Neoplasms
Point Mutation
Codon
Microsatellite Repeats
Introns
Exons
Nucleotides
Genes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Powell, S. M., Harper, J. C., Hamilton, S. R., Robinson, C. R., & Cummings, O. W. (1997). Inactivation of Smad4 in gastric carcinomas. Cancer Research, 57(19), 4221-4224.

Inactivation of Smad4 in gastric carcinomas. / Powell, Steven M.; Harper, Jeffrey C.; Hamilton, Stanley R.; Robinson, C. Rahj; Cummings, Oscar W.

In: Cancer Research, Vol. 57, No. 19, 01.10.1997, p. 4221-4224.

Research output: Contribution to journalArticle

Powell, SM, Harper, JC, Hamilton, SR, Robinson, CR & Cummings, OW 1997, 'Inactivation of Smad4 in gastric carcinomas', Cancer Research, vol. 57, no. 19, pp. 4221-4224.
Powell SM, Harper JC, Hamilton SR, Robinson CR, Cummings OW. Inactivation of Smad4 in gastric carcinomas. Cancer Research. 1997 Oct 1;57(19):4221-4224.
Powell, Steven M. ; Harper, Jeffrey C. ; Hamilton, Stanley R. ; Robinson, C. Rahj ; Cummings, Oscar W. / Inactivation of Smad4 in gastric carcinomas. In: Cancer Research. 1997 ; Vol. 57, No. 19. pp. 4221-4224.
@article{009d3c52c35548578694bb92e68eeb55,
title = "Inactivation of Smad4 in gastric carcinomas",
abstract = "Allelic loss of chromosome 18q has been noted in intestinal type gastric adenocarcinomas. Smad4 is a gene located at 18q that was recently cloned in humans and found to be significantly altered in pancreatic cancers. We sought to determine whether Smad4 genetic alterations played a significant role in gastric tumorigenesis by studying 35 gastric adenocarcinomas of all histopathological types and pathological stages. Microdissected specimens were used for mutational analysis of Smad4 at the nucleotide level, including the entire coding region and intron/exon boundaries. Allelic imbalance was also analyzed at the Smad4 locus using two nearby micro-satellite markers. One case of apparent biallelic inactivation of Smad4 was found in our study of 35 gastric carcinomas. A nonsense point mutation at codon 334 was demonstrated, which, similar to other Smad4 mutations, is predicted to truncate the conserved COOH-terminal domain of this protein. This Smad4 C to T transition mutation was proven to be somatically acquired. Allelic loss was also noted on chromosome 18q at a marker near Smad4 in this mutated gastric cancer, apparently producing complete inactivation of Smad4 in this tumor. Significant 18q allelic loss (56{\%} of 34 informative cases) was noted in our gastric carcinomas using microsatellite markers near the Smad4 locus, regardless of histological subtype or pathological stage. Additionally, three cases of microsatellite instability were observed. Thus, Smad4 inactivation was noted in our gastric carcinomas; however, this event was rare. The frequent loss of chromosomal arm 18q observed in gastric cancers suggests the presence of other tumor suppressor genes in this region that are involved in gastric tumorigenesis. Further studies are needed to identify these other targets of inactivation during gastric cancer development.",
author = "Powell, {Steven M.} and Harper, {Jeffrey C.} and Hamilton, {Stanley R.} and Robinson, {C. Rahj} and Cummings, {Oscar W.}",
year = "1997",
month = "10",
day = "1",
language = "English (US)",
volume = "57",
pages = "4221--4224",
journal = "Cancer Research",
issn = "0008-5472",
number = "19",

}

TY - JOUR

T1 - Inactivation of Smad4 in gastric carcinomas

AU - Powell, Steven M.

AU - Harper, Jeffrey C.

AU - Hamilton, Stanley R.

AU - Robinson, C. Rahj

AU - Cummings, Oscar W.

PY - 1997/10/1

Y1 - 1997/10/1

N2 - Allelic loss of chromosome 18q has been noted in intestinal type gastric adenocarcinomas. Smad4 is a gene located at 18q that was recently cloned in humans and found to be significantly altered in pancreatic cancers. We sought to determine whether Smad4 genetic alterations played a significant role in gastric tumorigenesis by studying 35 gastric adenocarcinomas of all histopathological types and pathological stages. Microdissected specimens were used for mutational analysis of Smad4 at the nucleotide level, including the entire coding region and intron/exon boundaries. Allelic imbalance was also analyzed at the Smad4 locus using two nearby micro-satellite markers. One case of apparent biallelic inactivation of Smad4 was found in our study of 35 gastric carcinomas. A nonsense point mutation at codon 334 was demonstrated, which, similar to other Smad4 mutations, is predicted to truncate the conserved COOH-terminal domain of this protein. This Smad4 C to T transition mutation was proven to be somatically acquired. Allelic loss was also noted on chromosome 18q at a marker near Smad4 in this mutated gastric cancer, apparently producing complete inactivation of Smad4 in this tumor. Significant 18q allelic loss (56% of 34 informative cases) was noted in our gastric carcinomas using microsatellite markers near the Smad4 locus, regardless of histological subtype or pathological stage. Additionally, three cases of microsatellite instability were observed. Thus, Smad4 inactivation was noted in our gastric carcinomas; however, this event was rare. The frequent loss of chromosomal arm 18q observed in gastric cancers suggests the presence of other tumor suppressor genes in this region that are involved in gastric tumorigenesis. Further studies are needed to identify these other targets of inactivation during gastric cancer development.

AB - Allelic loss of chromosome 18q has been noted in intestinal type gastric adenocarcinomas. Smad4 is a gene located at 18q that was recently cloned in humans and found to be significantly altered in pancreatic cancers. We sought to determine whether Smad4 genetic alterations played a significant role in gastric tumorigenesis by studying 35 gastric adenocarcinomas of all histopathological types and pathological stages. Microdissected specimens were used for mutational analysis of Smad4 at the nucleotide level, including the entire coding region and intron/exon boundaries. Allelic imbalance was also analyzed at the Smad4 locus using two nearby micro-satellite markers. One case of apparent biallelic inactivation of Smad4 was found in our study of 35 gastric carcinomas. A nonsense point mutation at codon 334 was demonstrated, which, similar to other Smad4 mutations, is predicted to truncate the conserved COOH-terminal domain of this protein. This Smad4 C to T transition mutation was proven to be somatically acquired. Allelic loss was also noted on chromosome 18q at a marker near Smad4 in this mutated gastric cancer, apparently producing complete inactivation of Smad4 in this tumor. Significant 18q allelic loss (56% of 34 informative cases) was noted in our gastric carcinomas using microsatellite markers near the Smad4 locus, regardless of histological subtype or pathological stage. Additionally, three cases of microsatellite instability were observed. Thus, Smad4 inactivation was noted in our gastric carcinomas; however, this event was rare. The frequent loss of chromosomal arm 18q observed in gastric cancers suggests the presence of other tumor suppressor genes in this region that are involved in gastric tumorigenesis. Further studies are needed to identify these other targets of inactivation during gastric cancer development.

UR - http://www.scopus.com/inward/record.url?scp=0030775491&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030775491&partnerID=8YFLogxK

M3 - Article

C2 - 9331080

AN - SCOPUS:0030775491

VL - 57

SP - 4221

EP - 4224

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 19

ER -